YSS:NYSEYork Space Systems Inc. Analysis
Data as of 2026-06-07 - not real-time
$29.14
Latest Price
8/10Risk
Risk Level: High
Executive Summary
York Space Systems trades at $29.14, sitting below its 20‑day (30.13) and 50‑day (31.19) SMAs while remaining just above the 200‑day SMA (28.27), indicating a short‑term pull‑back within a neutral longer trend. The RSI of 46.9 and a bearish MACD histogram reinforce the technical downside pressure, and volume is on a decreasing trajectory. Volatility is extreme at 131% over the past 30 days and the stock’s beta of 2.31 signals heightened sensitivity to market swings. Fundamentally, the company posts a 9.5% revenue growth year‑over‑year, yet operating margins are deeply negative (‑89.9%) and profit margins sit at ‑47.3%, with EBITDA and operating cash flow both in the red. The balance sheet shows a strong cash position ($656 M) offset by a very high debt‑to‑equity ratio of 10.36, and the forward P/E of 54.6 far exceeds the industry average of 30.2, suggesting the stock is overvalued. Recent headlines flag a securities‑fraud investigation, adding a material regulatory headwind, while earnings guidance was reaffirmed despite an earnings miss. Overall, the blend of aggressive valuation, weak profitability, elevated risk metrics, and pending legal scrutiny creates a cautious outlook, even as the space sector’s long‑term upside remains compelling.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD and decreasing volume
- Securities fraud investigation
- Price below short‑term moving averages
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- Revenue growth and government contract pipeline
- Strong cash cushion despite high debt
- Industry tailwinds in the space sector
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Overvalued price multiples relative to fundamentals
- High beta and volatility
- Potential upside from long‑term aerospace demand
Key Metrics & Analysis
Financial Health
Revenue Growth9.50%
Profit Margin-47.35%
P/E Ratio54.6
Debt/Equity10.36
P/B Ratio1.7
Op. Cash Flow$-126289000
Industry P/E30.2
Technical Analysis
TrendNeutral
RSI46.9
Support$23.39
Resistance$37.86
MA 20$30.13
MA 50$31.19
MA 200$28.27
MACDBearish
VolumeDecreasing
Fear & Greed Index83.02
Valuation
Target Price$34.67
Upside/Downside18.97%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.31
Volatility131.53%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.